Danish (OMX) Biotech Industry Analysis

UpdatedFeb 11, 2026

DataAggregated Company Financials

Companies5

7D-6.3%
3M-3.9%
1Y10.1%
YTD-4.1%

Over the last 7 days, the Biotech industry has dropped 6.0%, driven by a pullback from Genmab of 7.6%. In the past year, the industry has gained 9.9%. In the next few years, earnings are forecast to decline by 6.5% annually.

Industry Valuation and Performance

Has the Danish Biotech Industry valuation changed over the past few years?

Date	Market Cap	Revenue	Earnings	PE	Absolute PE	PS
Wed, 11 Feb 2026	DKK 164.5b	DKK 40.2b	DKK 18.8b	6.2x	8.7x	4.1x
Fri, 09 Jan 2026	DKK 178.5b	DKK 40.7b	DKK 19.0b	6.4x	9.4x	4.4x
Sun, 07 Dec 2025	DKK 176.4b	DKK 40.7b	DKK 19.1b	6.1x	9.3x	4.3x
Tue, 04 Nov 2025	DKK 167.9b	DKK 39.2b	DKK 16.9b	12.9x	9.9x	4.3x
Thu, 02 Oct 2025	DKK 175.7b	DKK 38.8b	DKK 16.7b	12.6x	10.5x	4.5x
Sat, 30 Aug 2025	DKK 147.5b	DKK 38.9b	DKK 16.8b	11.2x	8.8x	3.8x
Mon, 28 Jul 2025	DKK 137.1b	DKK 26.9b	DKK 7.3b	13.2x	18.8x	5.1x
Wed, 25 Jun 2025	DKK 121.9b	DKK 27.1b	DKK 7.4b	10.6x	16.5x	4.5x
Fri, 23 May 2025	DKK 128.7b	DKK 28.0b	DKK 7.9b	10.5x	16.3x	4.6x
Sun, 20 Apr 2025	DKK 124.4b	DKK 27.3b	DKK 7.7b	11.2x	16.2x	4.6x
Tue, 18 Mar 2025	DKK 143.4b	DKK 27.3b	DKK 7.7b	12.2x	18.7x	5.2x
Thu, 13 Feb 2025	DKK 151.2b	DKK 26.0b	DKK 4.7b	15.2x	32.2x	5.8x
Sat, 11 Jan 2025	DKK 170.6b	DKK 26.0b	DKK 4.7b	17.9x	36.3x	6.6x
Mon, 09 Dec 2024	DKK 173.1b	DKK 26.0b	DKK 4.7b	17.8x	36.9x	6.6x
Wed, 06 Nov 2024	DKK 172.1b	DKK 25.5b	DKK 5.5b	20.2x	31.4x	6.8x
Fri, 04 Oct 2024	DKK 175.3b	DKK 25.5b	DKK 5.5b	21.6x	32x	6.9x
Sun, 01 Sep 2024	DKK 203.5b	DKK 25.5b	DKK 5.5b	25.4x	37.2x	8x
Tue, 30 Jul 2024	DKK 201.3b	DKK 24.8b	DKK 5.6b	18.6x	35.7x	8.1x
Thu, 27 Jun 2024	DKK 183.5b	DKK 24.8b	DKK 5.6b	17.6x	32.6x	7.4x
Sat, 25 May 2024	DKK 175.6b	DKK 24.8b	DKK 5.6b	18.5x	31.2x	7.1x
Mon, 22 Apr 2024	DKK 178.7b	DKK 23.9b	DKK 5.0b	18.9x	35.5x	7.5x
Wed, 20 Mar 2024	DKK 189.8b	DKK 23.9b	DKK 5.0b	19.3x	37.8x	7.9x
Fri, 16 Feb 2024	DKK 172.9b	DKK 22.8b	DKK 4.2b	23.5x	41x	7.6x
Sun, 14 Jan 2024	DKK 182.0b	DKK 23.3b	DKK 4.2b	25.5x	43.7x	7.8x
Tue, 12 Dec 2023	DKK 178.5b	DKK 23.3b	DKK 4.2b	26x	42.9x	7.7x
Thu, 09 Nov 2023	DKK 170.8b	DKK 22.7b	DKK 4.3b	21.7x	39.8x	7.5x
Sat, 07 Oct 2023	DKK 193.2b	DKK 22.0b	DKK 4.7b	22.7x	40.8x	8.8x
Mon, 04 Sep 2023	DKK 200.9b	DKK 22.0b	DKK 4.7b	23.8x	42.5x	9.1x
Wed, 02 Aug 2023	DKK 203.7b	DKK 19.5b	DKK 4.4b	35.2x	46.2x	10.4x
Fri, 30 Jun 2023	DKK 195.0b	DKK 19.5b	DKK 4.4b	40.9x	44.3x	10x
Sun, 28 May 2023	DKK 214.9b	DKK 19.5b	DKK 4.4b	42.1x	48.8x	11x
Tue, 25 Apr 2023	DKK 211.6b	DKK 17.9b	DKK 3.5b	33.1x	59.8x	11.8x
Thu, 23 Mar 2023	DKK 191.2b	DKK 17.9b	DKK 3.5b	29.9x	53.9x	10.7x
Sat, 18 Feb 2023	DKK 208.8b	DKK 14.7b	DKK 3.3b	31.9x	63.8x	14.2x

Price to Earnings Ratio

63.8x

Sat, 18 Feb 2023

Current Industry PE

Investors are pessimistic on the Danish Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.

The industry is trading at a PE ratio of 8.7x which is lower than its 3-year average PE of 31.8x.

The 3-year average PS ratio of 7.1x is higher than the industry's current PS ratio of 4.1x.

Past Earnings Growth

The earnings for companies in the Biotechs industry have grown 79% per year over the last three years.
Revenues for these companies have grown 40% per year.
This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.